Ready-to Use CHO cell lines

Ready-to Use CHO cell lines
Product Description

UGA Biopharma GmbH offers to their clients Ready-to-use Biosimilar Cell Lines. These are in-house developed CHO cell lines stably expressing different blockbuster biosimilar molecules, that are instantly available for in-licensing. The client profits of direct availability of cell lines banks and prompt accessibility of crucial developmental data including titer and quality attributes. R2U offered include Adalimumab, Alglucosidase alfa, Bevacizumab, Pembrolizumab, Daratumumab, Trastuzumab, in addition to many other cell lines. Visit our booth to know all the available cell lines & products!

Read more Show less

UGA Biopharma GmbH

  • Country/Region:
    Germany
  • Founded:
    2009
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Primary activities
Biopharmaceutical
Contract Research Organisation
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Convenience; Place of Origin; Price; Product Performance; Prompt Delivery; Quality Service; Reputation
  • Supplied from
    Germany
More specifications Fewer specifications
Sales Markets
Show more Show less

UGA Biopharma GmbH

  • Country/Region:
    Germany
  • Founded:
    2009
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Primary activities
Biopharmaceutical
Contract Research Organisation
View company profile

More Products from UGA Biopharma GmbH (2)

  • Cell Line Development services

    Product Cell Line Development services

    Cell line development services, including molecular cloning, CHO cell line development and lead clone selection, upstream bioprocess optimization, Down stream bioprocessing and analytical characterization of the target molecule. In addition to a detailed documentation in line with regulatory requirement...
  • CHO Prime® Media & Feeds for CHO cell culture

    Product CHO Prime® Media & Feeds for CHO cell culture

    CHO Prime® is a next-generation, GMP-compliant, adaptive media platform designed to maximise productivity while giving you precise control over critical quality attributes, particularly glycosylation. Built for production of biologics and biosimilars, CHO Prime® combines chemically defined, animal componen...